Subscribe to RSS
DOI: 10.1055/s-0045-1810064
MR Lymphangiography in Pediatrics: Indications, Technique, Findings, and Management
Funding None of the authors received any funding for this project.

Abstract
Over the past two decades, magnetic resonance imaging (MRI) has become the mainstay for lymphatic imaging in pediatric patients suffering from lymphatic disorders caused by congenital or acquired causes. Pediatric patients, especially those born with complex congenital heart disease, status post single ventricle palliation increasingly constitute the largest group of patients presenting with lymphatic dysfunction. Heavily T2-weighted and 3D-balanced steady-state free precession are complementary MRI sequences used for noninvasive assessment of the central lymphatic anatomy as well as distribution of lymphatic fluid in body cavities, lymphatic cysts, and lymphatic malformations. These sequences are, however, limited in their ability to visualize smaller lymphatics, to differentiate lymphatics from other fluid-filled structures, or to provide sequential flow information. This limitation is overcome by administering a gadolinium-based contrast agent into a lymph node, lymphatic vessel, or interstitial tissue with simultaneous image acquisition, a technique called dynamic contrast-enhanced magnetic resonance lymphangiography. This imaging is invasive but critical for evaluating lymphatic flow and identifying potential targets for lymphatic intervention. Medical therapy, along with traditional transcatheter or surgical approaches to address the underlying cause of the lymphatic disorder, remains the first-line approach, while lymphatic interventions are reserved for patients who have failed these therapies.
Keywords
dynamic contrast-enhanced MR lymphangiography - chylothorax - plastic bronchitis - chylous ascites - protein-losing enteropathy - interventional radiologyPublication History
Article published online:
16 July 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Dori Y, Zviman MM, Itkin M. Dynamic contrast-enhanced MR lymphangiography: feasibility study in swine. Radiology 2014; 273 (02) 410-416
- 2 Krishnamurthy R, Hernandez A, Kavuk S, Annam A, Pimpalwar S. Imaging the central conducting lymphatics: initial experience with dynamic MR lymphangiography. Radiology 2015; 274 (03) 871-878
- 3 Benjamin J, O'Leary C, Hur S, Gurevich A, Klein WM, Itkin M. Imaging and interventions for lymphatic and lymphatic-related disorders. Radiology 2023; 307 (03) e220231
- 4 Nriagu BN, Adams DM, Srinivasan A. et al. Multicompartment dynamic contrast magnetic resonance lymphangiography in diagnosis of complicated lymphatic anomaly. Lymphat Res Biol 2023; 21 (02) 135-140
- 5 Dori Y, Smith CL, DeWitt AG. et al. Intramesenteric dynamic contrast pediatric MR lymphangiography: initial experience and comparison with intranodal and intrahepatic MR lymphangiography. Eur Radiol 2020; 30 (10) 5777-5784
- 6 Chavhan GB, Amaral JG, Temple M, Itkin M. MR lymphangiography in children: technique and potential applications. Radiographics 2017; 37 (06) 1775-1790
- 7 Ghandour MAH, Sinha SP. How to start a lymphatic program. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2023; 26: 18-25
- 8 Hur S, Kim J, Ratnam L, Itkin M. Lymphatic intervention, the frontline of modern lymphatic medicine: part I. History, anatomy, physiology, and diagnostic imaging of the lymphatic system. Korean J Radiol 2023; 24 (02) 95-108
- 9 Biko DM, DeWitt AG, Pinto EM. et al. MRI evaluation of lymphatic abnormalities in the neck and thorax after Fontan surgery: relationship with outcome. Radiology 2019; 291 (03) 774-780
- 10 RochéRodríguez M, DiNardo JA. The lymphatic system in the Fontan patient—pathophysiology, imaging, and interventions: what the anesthesiologist should know. J Cardiothorac Vasc Anesth 2022; 36 (8 Pt A): 2669-2678
- 11 Itkin M, Pizarro C, Radtke W, Spurrier E, Rabinowitz DA. Lymphatic management in single-ventricle patients. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2020; 23: 41-47
- 12 Pedrosa I, Altman DA, Dillman JR. et al. American College of Radiology Manual on MR Safety: 2024 update and revisions. Radiology 2025; 315 (01) e241405
- 13 Gooty VD, Veeram Reddy SR, Greer JS. et al. Lymphatic pathway evaluation in congenital heart disease using 3D whole-heart balanced steady state free precession and T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2021; 23 (01) 16
- 14 Hussain T, Lossnitzer D, Bellsham-Revell H. et al. Three-dimensional dual-phase whole-heart MR imaging: clinical implications for congenital heart disease. Radiology 2012; 263 (02) 547-554
- 15 Young DF, Reddy SV, Divekar A. et al. Enhancement of the lymphatic system following intravenous administration of ferumoxytol. Pediatr Radiol 2024; 54 (12) 2060-2067
- 16 Smith CL, Liu M, Saravanan M. et al. Liver lymphatic anatomy and role in systemic lymphatic disease. Eur Radiol 2022; 32 (01) 112-121
- 17 Mackie AS, Veldtman GR, Thorup L, Hjortdal VE, Dori Y. Plastic bronchitis and protein-losing enteropathy in the Fontan patient: evolving understanding and emerging therapies. Can J Cardiol 2022; 38 (07) 988-1001
- 18 Pinto E, Dori Y, Smith C. et al. Neonatal lymphatic flow disorders: impact of lymphatic imaging and interventions on outcomes. J Perinatol 2021; 41 (03) 494-501
- 19 Pieper CC, Wagenpfeil J, Henkel A. et al. MR lymphangiography of lymphatic abnormalities in children and adults with Noonan syndrome. Sci Rep 2022; 12 (01) 11164
- 20 Swarts JW, Kleimeier LER, Leenders EKSM, Rinne T, Klein WM, Draaisma JMT. Lymphatic anomalies during lifetime in patients with Noonan syndrome: retrospective cohort study. Am J Med Genet A 2022; 188 (11) 3242-3261
- 21 Kleimeier LER, van Schaik C, Leenders E, Itkin M, Klein WM, Draaisma JMT. Lymphatic phenotype of Noonan syndrome: innovative diagnosis and possible implications for therapy. J Clin Med 2022; 11 (11) 3128
- 22 Itkin M, Chen EH. Thoracic duct embolization. Semin Intervent Radiol 2011; 28 (02) 261-266
- 23 Kim PH, Tsauo J, Shin JH. Lymphatic interventions for chylothorax: a systematic review and meta-analysis. J Vasc Interv Radiol 2018; 29 (02) 194-202.e4
- 24 Laslett D, Trerotola SO, Itkin M. Delayed complications following technically successful thoracic duct embolization. J Vasc Interv Radiol 2012; 23 (01) 76-79
- 25 Kariya S, Nakatani M, Ono Y. et al. Percutaneous balloon plasty for thoracic duct occlusion in a patient with chylothorax and chylous ascites. Cardiovasc Intervent Radiol 2019; 42 (05) 779-783
- 26 Zurcher KS, Huynh KN, Khurana A. et al. Interventional management of acquired lymphatic disorders. Radiographics 2022; 42 (06) 1621-1637
- 27 Srinivasan A, Smith C, Krishnamurthy G, Escobar F, Biko D, Dori Y. Characterization and treatment of thoracic duct obstruction in patients with lymphatic flow disorders. Catheter Cardiovasc Interv 2023; 101 (05) 853-862
- 28 Hoa TQ, Cuong NN, Hoan L. et al. Occlusion of thoracic duct stent resulting in recurrent chyluria: role of renal-lymphatic fistula embolization. CVIR Endovasc 2023; 6 (01) 39
- 29 Mäkinen T, Boon LM, Vikkula M, Alitalo K. Lymphatic malformations: genetics, mechanisms and therapeutic strategies. Circ Res 2021; 129 (01) 136-154
- 30 Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest 2014; 124 (03) 898-904
- 31 Grenier JM, Borst AJ, Sheppard SE. et al. Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly. Pediatr Blood Cancer 2023; 70 (09) e30419
- 32 Ozeki M, Endo S, Yasue S. et al. Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial. Front Med (Lausanne) 2024; 11: 1335469
- 33 Sheppard SE, March ME, Seiler C. et al. Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition. JCI Insight 2023; 8 (09) e155888
- 34 Li D, March ME, Gutierrez-Uzquiza A. et al. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Nat Med 2019; 25 (07) 1116-1122
- 35 Hribernik I, Brooks T, Dunlop-Jones A, Bentham JR. Successful treatment of refractory chylothorax with MEK inhibitor trametinib in a child with Noonan syndrome: case report. Eur Heart J Case Rep 2023; 7 (04) ytad190
- 36 Reisen B, Kovach SJ, Levin LS. et al. Thoracic duct-to-vein anastomosis for the management of thoracic duct outflow obstruction in newborns and infants: a CASE series. J Pediatr Surg 2020; 55 (02) 234-239
- 37 Hraška V. Decompression of thoracic duct: new approach for the treatment of failing Fontan. Ann Thorac Surg 2013; 96 (02) 709-711
- 38 Hraska V, Hjortdal VE, Dori Y, Kreutzer C. Innominate vein turn-down procedure: killing two birds with one stone. JTCVS Tech 2021; 7: 253-260
- 39 Smith CL, Hoffman TM, Dori Y, Rome JJ. Decompression of the thoracic duct: a novel transcatheter approach. Catheter Cardiovasc Interv 2020; 95 (02) E56-E61